Skip to main content
. 2019 Oct 14;9(10):e029542. doi: 10.1136/bmjopen-2019-029542

Table 1.

Demographic characteristics (n=1060)

Variable Value
Demographic
 Age in years, mean (SD) 54.6 (12.2)
 Female sex, n (%) 932 (88)
 Education in years, mean (SD) 15.0 (3.6)
 Married or living as married, n (%) 751 (71)
 Country, n (%)
  Canada 273 (26)
  USA 416 (39)
  UK 117 (11)
  France 218 (21)
  Spain 32 (3)
  Mexico 4 (0)
Disease characteristics
 Time since onset first non-Raynaud’s symptom or sign in years, mean (SD) 11.3 (8.5)
 Time since onset Raynaud’s in years, mean (SD)* 14.6 (11.6)
 Time since diagnosis in years, mean (SD) 9.4 (7.8)
 Diffuse disease subtype, n (%) 439 (41.4)
 Modified Rodnan Skin Score, mean (SD) 8.1 (8.6)
Signalling question scores
 Fatigue, mean (SD) 6.8 (3.2)
 Hand function and mobility, mean (SD) 6.8 (3.4)
 Sleep problems, mean (SD) 6.0 (3.7)
 Emotions and stress, mean (SD) 5.8 (3.6)
 Body image and appearance, mean (SD) 5.1 (3.7)
 Pain, mean (SD) 6.3 (3.4)
 Self-management/coping strategies, mean (SD) 6.6 (3.3)
 Nutrition/diet, mean (SD) 6.9 (3.2)
 Exercise, mean (SD) 7.0 (2.9)
Patient-reported outcome measures
 Self-efficacy to Manage Chronic Disease Scale, mean (SD) 6.3 (2.2)
 PROMIS-29 fatigue, mean (SD) 55.9 (10.7)
 PROMIS-29 sleep, mean (SD) 52.8 (8.6)
 PROMIS-29 depression, mean (SD) 51.7 (9.3)
 PROMIS-29 pain, mean (SD) 56.4 (9.3)
 Cochin Hand Function Scale, mean (SD) 14.7 (16.4)
 Social Appearance Anxiety Scale, mean (SD) 29.6 (13.7)
 Interference from gastrointestinal problems, mean (SD) 2.7 (3.0)
 Physical activity, mean (SD) 1.7 (1.1)

*Due to missing data: N=986.

†Due to missing data: N=1053.

‡Due to missing data: N=879.

PROMIS-29, Patient-Reported Outcomes Measurement Information System-29.